Changes

no edit summary
Line 306: Line 306:  
|
 
|
 
|-
 
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
+
|[[Adenoid Cystic Carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
 
|10/12/02022
 
|10/12/02022
 
|11/11/2023
 
|11/11/2023
Line 315: Line 315:  
|2021 template added
 
|2021 template added
 
|-
 
|-
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
+
|[[Secretory Carcinoma]]||Disease||Hui Chen / Morteza Seifi
 
|10/12/2022
 
|10/12/2022
 
|11/11/2023
 
|11/11/2023
Line 342: Line 342:  
|
 
|
 
|-
 
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
+
|[[Tall Cell Carcinoma with Reversed Polarity]]||Disease||H. Evin Gulbahce
 
|8/11/2023
 
|8/11/2023
 
|10/11/2023
 
|10/11/2023
Line 378: Line 378:  
|
 
|
 
|-
 
|-
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
+
|[[Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 387: Line 387:  
|2021 template added
 
|2021 template added
 
|-
 
|-
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
+
|[[Phyllodes Tumour]]||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 495: Line 495:  
|
 
|
 
|-
 
|-
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
+
|[[Inflammatory Myofibroblastic Tumour]]||Disease||Yajuan Liu
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 747: Line 747:  
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|-
|Polygenic Component of Breast Cancer Susceptibility
+
|[[Polygenic Component of Breast Cancer Susceptibility]]
 
|Disease
 
|Disease
 
|
 
|
Line 756: Line 756:  
|
 
|
 
|
 
|
|
+
|Template added (12/30/23)
 
|-
 
|-
 
|}<br />
 
|}<br />